Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials

Theodore Bowe; Mirataollah Salabati; Rebecca R Soares; Charles Huang; Rishi P Singh; M Ali Khan; Basil K Williams Jr; Jayanth Sridhar; Allen Chiang; Michael N Cohen; Michael A Klufas; Omesh P Gupta; Yoshihiro Yonekawa; David Xu; Ajay E Kuriyan

doi:10.1016/j.oret.2022.01.018

Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials

Ophthalmol Retina. 2022 Jun;6(6):531-533. doi: 10.1016/j.oret.2022.01.018. Epub 2022 Feb 4.

Authors

Affiliations

¹ Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania.
² Center for Ophthalmic Bioinformatics Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
³ Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
⁴ Bascom Palmer Eye Institute, University of Miami, Miami, Florida.
⁵ Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: ajay.kuriyan@gmail.com.

PMID: 35131526
DOI: 10.1016/j.oret.2022.01.018

Abstract

Subjects in diabetic macular edema clinical trials in the United States are disproportionately White and male, compared with the population undergoing treatment for diabetic macular edema.

Keywords: Clinical Trials; Diabetes; Diabetic Macular Edema; Racial Disparities.

MeSH terms

Diabetes Mellitus*
Diabetic Retinopathy* / epidemiology
Diabetic Retinopathy* / therapy
Ethnicity
Healthcare Disparities* / ethnology
Humans
Macular Edema* / drug therapy
Macular Edema* / therapy
Male
Racial Groups
Sex Factors
United States / epidemiology